Stockscreener 앱 받기
95.41
3.01%
2.82
전일 마감가:
$92.59
열려 있는:
$92.95
하루 거래량:
668.65K
Relative Volume:
0.30
시가총액:
$18.88B
수익:
$7.68B
순이익/손실:
$903.80M
주가수익비율:
21.44
EPS:
4.45
순현금흐름:
$1.14B
1주 성능:
+1.44%
1개월 성능:
+4.56%
6개월 성능:
-13.07%
1년 성능:
-13.55%
1일 변동 폭
$92.58
$95.41
1주일 범위
$92.58
$95.60
52주 변동 폭
$89.24
$116.71
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.41 | 18.57B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
124.94 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.90 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
392.94 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.07 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
What drives Zimmer Biomet Holdings Inc. stock priceDynamic profit expansion - jammulinksnews.com
Is Zimmer Biomet Holdings Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
What analysts say about Zimmer Biomet Holdings Inc. stockExceptional stock performance - Autocar Professional
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA (NYSE:ZBH) - Seeking Alpha
Jim Cramer Expresses Bullishness on Zimmer’s Acquisition of Monogram Technologies - MSN
Zimmer Biomet Holdings Inc. Stock Analysis and ForecastPowerful growth strategies - PrintWeekIndia
What You Need To Know Ahead of Zimmer Biomet's Earnings Release - MSN
Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) - MSN
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal - MSN
Jim Cramer Bullish on Zimmer Biomet's Acquisition of Monogram Technologies - AInvest
Zimmer Expands Robotics Portfolio Acquiring Monogram Technologies for $177 Million - MSN
Zimmer Biomet Holdings Surges to 444th in Market Rankings with $235 Million Trading Volume - AInvest
Zimmer Biomet’s SWOT analysis: stock faces challenges amid strategic acquisitions - Investing.com Australia
Zimmer Biomet Q2 Earnings Preview: Navigating Market ChallengesNews and Statistics - IndexBox
What You Need To Know Ahead Of Zimmer Biomet's Earnings Release - Barchart.com
17 Stocks on Jim Cramer’s Radar - Insider Monkey
Zimmer bets on autonomous surgery with Monogram purchase - Yahoo Finance
Zimmer Biomet wins price target raise at Roth - Cantech Letter
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
BTIG Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Zimmer upgraded to Buy at Roth Capital on Monogram deal (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - AI Insider
Wall Street's Top Analyst Calls: Upgrades and Downgrades for Zimmer Biomet, Southwest, DoorDash, and More - AInvest
What Makes Zimmer Biomet Holdings (ZBH) an Investment Opportunity? - Insider Monkey
Zimmer Biomet Merges with Monogram Technologies - The Globe and Mail
Zimmer Biomet to acquire Monogram for $177m - Yahoo Finance
Zimmer Biomet Acquires Monogram Technologies for $144M in Cash and Earnout - AInvest
Why Zimmer Biomet Holdings Inc. stock attracts strong analyst attentionFree Stock Market Entry & Exit Signals - beatles.ru
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Monogram Technologies Inc. (NASDAQ: MGRM) - GlobeNewswire Inc.
Zimmer Biomet Announces Definitive Agreement To Acquire Monogram - timesuniononline.com
Zimmer Biomet to acquire Monogram Technologies for $177M - The Robot Report
Small Healthcare Stocks Enjoy Big Wins On Deal News - Finimize
Zimmer Biomet to buy Monogram for $177M in cash - MSN
Zimmer Biomet Holdings, Inc. agreed to acquire Monogram Technologies Inc. for $144 million. - MarketScreener
Su Group Holdings Limited shares rise 9.62% intraday due to Zimmer Biomet's acquisition of Monogram Technologies. - AInvest
Zimmer Biomet to acquire Texas orthopedic robotics company - Inside INdiana Business
Zimmer Biomet in $168M buy of ortho robotics maker Monogram - BioWorld MedTech
Zimmer Biomet to Acquire Monogram Technologies for $177M to Offer First Fully Autonomous Surgical Robot - HIT Consultant
Zimmer Biomet Bets Big On Robotic Surgery With $177 Million Deal - Finimize
Zimmer Biomet to acquire robotics company Monogram Technologies - Modern Healthcare
Zimmer Biomet acquisition of Monogram Technologies to expand capacity in robotics devices - The Journal Gazette
Citi maintains Neutral rating on Zimmer Biomet stock amid Monogram acquisition - Investing.com
Zimmer Biomet Holdings (ZBH) Announces Merger Agreement with Mon - GuruFocus
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.66%
0.08%
자본화:
|
볼륨(24시간):